Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127199) titled 'Efficacy of Early Administration of Human Intravenous Immunoglobulin for Kawasaki Disease in Children: A Multicenter, Prospective, Randomized Controlled Clinical Trial' on June 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Guangzhou Women and Children's Medical Center,Guangzhou Medical University

Condition: Kawasaki Disease

Intervention: Experimental (early treatment) group:Intravenous immunoglobulin (IVIG) was administered within 4 days of disease onset.

Phase: N/A

Date of First Enrollment: 2026-06-27

Target Sample Size: Experimental (early treatment) group:35;Control (s...